Australia's Telix Agrees to Buy Germany's ITM Isotope for $1.65 Billion

3-line summary

• Australia's Telix Pharmaceuticals agreed to buy Germany's ITM Isotope for $1.65 billion, according to Investing.com.

This summary is our own processing of the source article; see the source link below for full context.